指南与共识炎症性肠病消化道肿瘤与早癌消化内镜

英国胃肠病学会炎症性肠病结直肠监测指南

British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease.
指南 / 共识 · Gut · 2025-04-30

该指南由代表英国医师、内镜医师、外科医师、专科护士和患者的利益相关方制定,并获GRADE方法学支持,是对2010年指南的更新,适用于16岁以上结肠型炎症性肠病患者的结直肠监测。基于对7599篇文献的系统评价及GRADE分析,共形成73条陈述,涵盖癌症风险、风险分层、内镜方式、不典型增生管理及服务组织等核心领域,并提出16项研究优先方向。

要点

  • 提出73条陈述指导炎症性肠病结直肠监测服务,包括服务与内镜医师审计的结果标准。
  • 强调与患者共同决策的重要性,并涉及监测的启动与停止及风险分层。
  • 涵盖内镜方式、化学预防、不典型增生管理及多学科团队作用等核心领域。

核心结论

  • 尽管晚期治疗改善了炎症控制、结肠镜监测普及且环境危险因素减少,炎症性肠病患者结直肠癌及结直肠癌死亡风险仍高于一般人群。
  • 本指南为16岁以上结肠型炎症性肠病患者提供结直肠监测的73条陈述,并建议16项研究优先方向。

研究设计与样本

  • 由代表英国医师、内镜医师、外科医师、专科护士和患者的利益相关方制定,并获GRADE方法学支持。
  • 预先发表方案,描述三级陈述(GRADE推荐、良好实践声明或专家意见声明)的制定方法。
  • 对7599篇文献进行系统评价,并在适当情况下对试验进行评价和GRADE分析及网状Meta分析,以风险阈值指导GRADE判断。

主要发现

  • 共形成73条用于炎症性肠病结直肠监测服务实施的陈述,包括服务与内镜医师审计的结果标准。
  • 核心领域包括结直肠癌风险、炎症性肠病相关结肠镜后结直肠癌、服务组织与患者依从性支持、监测的启动与停止及适用人群。
  • 核心领域还包括风险分层(含基于网络的监测间隔多变量风险计算)、结肠镜方式、肠道准备、生物标志物与人工智能辅助检测、化学预防。
  • 核心领域还涉及非传统不典型增生、锯齿状病变与非靶向活检的作用,不典型增生的内镜与外科管理,以及多学科团队的结构与作用。
  • 核心领域还涵盖炎症性肠病结肠镜监测培训、可持续性(绿色内镜)、成本效益与患者体验。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with inflammatory bowel disease (IBD) remain at increased risk for colorectal cancer and death from colorectal cancer compared with the general population despite improvements in inflammation control with advanced therapies, colonoscopic surveillance and reductions in environmental risk factors. This guideline update from 2010 for colorectal surveillance of patients over 16 years with colonic inflammatory bowel disease was developed by stakeholders representing UK physicians, endoscopists, surgeons, specialist nurses and patients with GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodological support.An a priori protocol was published describing the approach to three levels of statement: GRADE recommendations, good practice statements or expert opinion statements. A systematic review of 7599 publications, with appraisal and GRADE analysis of trials and network meta-analysis, where appropriate, was performed. Risk thresholding guided GRADE judgements.We made 73 statements for the delivery of an IBD colorectal surveillance service, including outcome standards for service and endoscopist audit, and the importance of shared decision-making with patients.Core areas include: risk of colorectal cancer, IBD-related post-colonoscopy colorectal cancer; service organisation and supporting patient concordance; starting and stopping surveillance, who should or should not receive surveillance; risk stratification, including web-based multivariate risk calculation of surveillance intervals; colonoscopic modalities, bowel preparation, biomarkers and artificial intelligence aided detection; chemoprevention; the role of non-conventional dysplasia, serrated lesions and non-targeted biopsies; management of dysplasia, both endoscopic and surgical, and the structure and role of the multidisciplinary team in IBD dysplasia management; training in IBD colonoscopic surveillance, sustainability (green endoscopy), cost-effectiveness and patient experience. Sixteen research priorities are suggested.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. East JE, Gordon M, Nigam GB, et al. British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut. 2025. PMID: 40306978. doi:10.1136/gutjnl-2025-335023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。